BridgeMD
New treatment option for Meningioma
Official title Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.
ClinicalTrials.gov ID: NCT06830356
What this study is testing
- What it's testing
- High-risk meningiomas always require postsurgical radiation treatment. Recent evidence has shown that increased radiation therapy dose may be associated with increased intracranial control of disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older
You may be able to join if
- Age ≥ 16 years;
- Ability to express appropriate informed consent to treatment;
- Diagnosis of grade III meningioma (regardless of presence of residual) or diagnosis of recurrence of grade II meningioma (regardless of presence of...
- In case of recurrence, confirmation can be either histological or radiological;
- Not previous brain-level radiotherapy;
You likely can't join if
- Refusal to radiation treatment (i.e., absence of signed informed consent);
- Other concomitant oncologic therapies
- Current pregnancy;
- Grade I meningiomas or Grade II meningiomas if operated on at first diagnosis with radical resection;
- Inability to perform MRI with MoC or PET.
See the full eligibility criteria
- Age ≥ 16 years;
- Ability to express appropriate informed consent to treatment;
- Diagnosis of grade III meningioma (regardless of presence of residual) or diagnosis of recurrence of grade II meningioma (regardless of presence of residual) or first diagnosis of grade II meningioma with presence of...
- In case of recurrence, confirmation can be either histological or radiological;
- Not previous brain-level radiotherapy;
- Performance status: ECOG=0-2.
- Refusal to radiation treatment (i.e., absence of signed informed consent);
- Other concomitant oncologic therapies
- Current pregnancy;
- Grade I meningiomas or Grade II meningiomas if operated on at first diagnosis with radical resection;
- Inability to perform MRI with MoC or PET.
The study team makes the final eligibility decision.
Where it's taking place
- Aviano, Pordenone, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aviano, Pordenone, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.